List of Skyhawk Therapeutics patents

Patent 11326165 was granted and assigned to Skyhawk Therapeutics on May, 2022 by the United States Patent and Trademark Office.

Patent 11434489 was granted and assigned to Skyhawk Therapeutics on September, 2022 by the United States Patent and Trademark Office.

Patent 11021708 was granted and assigned to Skyhawk Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Patent 11129829 was granted and assigned to Skyhawk Therapeutics on September, 2021 by the United States Patent and Trademark Office.

Patent 11530207 was granted and assigned to Skyhawk Therapeutics on December, 2022 by the United States Patent and Trademark Office.

Patent 11008572 was granted and assigned to Skyhawk Therapeutics on May, 2021 by the United States Patent and Trademark Office.

Patent 11162101 was granted and assigned to Skyhawk Therapeutics on November, 2021 by the United States Patent and Trademark Office.

Patent 11091475 was granted and assigned to Skyhawk Therapeutics on August, 2021 by the United States Patent and Trademark Office.

Patent 11964971 was granted and assigned to Skyhawk Therapeutics on April, 2024 by the United States Patent and Trademark Office.